Medi-Tech Insights Get in touch

Global Oral Proteins and Peptides Market Size, Share, Revenue Analysis & Trends Report Segmented by Molecule (Semaglutide, Calcitonin), Drug Class (GLP-1 & CGRP Receptor Agonists), Formulation (Tablets, Capsules, Oral Solutions), Therapeutic Area, End-user & Regional Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Oral Proteins and Peptides Marke"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Growing burden of chronic and lifestyle-related diseases
          • Advancements in oral drug delivery technologies
          • Growing patient preference for oral route of administration
          • Increased R&D investments by pharma and biotech companies
          • Adoption of AI-driven predictive modelling in formulation development
        • Restraints
          • High cost of drug development
          • Limited bioavailability and GI-related constraints
          • Manufacturing complexity and scalability limitations
        • Opportunities
          • Expansion into new therapeutic areas
          • Growing focus on personalized medicine
          • Increasing strategic collaboration among biopharma and tech companies accelerates innovation
        • Key Market Trends
          • Integration of AI in drug delivery
          • Rising focus on plant-based and naturally derived peptide
          • Unmet Market Needs
          • Industry Speaks
        • "5">
      • Global Oral Proteins and Peptides Market Size & Forecast (2024-2031), By Molecule, USD Million
        • Introduction
        • Semaglutide
        • Calcitonin
        • Linaclotide
        • Trofinetide
        • Voclosporin
        • Plecanatide
        • Others
  • Global Oral Proteins and Peptides Market Size & Forecast (2024-2031), By Drug Class, USD Million
    • Introduction
    • GLP-1 Receptor Agonists
    • CGRP Receptor Agonists
    • GC-C Agonists
    • GPE
    • Others
    1. Global Oral Proteins and Peptides Market Size & Forecast (2024-2031), By Formulation, USD Million
      • Introduction
      • Tablets
      • Capsules
      • Oral Solutions
    1. Global Oral Proteins and Peptides Market Size & Forecast (2024-2031), By Therapeutic Area, USD Million
      • Introduction
      • Diabetes
      • CNS Disorders
      • Gastroenterology
      • Genetic Disorders
      • Nephrology
      • Others
  • Global Oral Proteins and Peptides Market Size & Forecast (2024-2031), By End-user, USD Million
    • Introduction
    • Hospitals & Specialty Clinics
    • Home Care Settings
    • Long-term Care Settings
    • Others
  • Global Oral Proteins and Peptides Market Size & Forecast (2024-2031), By Region, USD Million
    • Introduction
    • North America Oral Proteins and Peptides Market Size & Forecast (2024-2031), By Country, USD Million
      • US
        • Market Size & Forecast, By Molecule (USD Million)
        • Market Size & Forecast, By Drug Class (USD Million)
        • Market Size & Forecast, By Formulation (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Canada
        • Market Size & Forecast, By Molecule (USD Million)
        • Market Size & Forecast, By Drug Class (USD Million)
        • Market Size & Forecast, By Formulation (USD Million)
        • Market Size & Forecast, By Therapeutic Area (USD Million)
        • Market Size & Forecast,tides Market Size & Forecast (2024-2031), By Country, USD Million
          • UK
            • Market Size & Forecast, By Molecule (USD Million)
            • Market Size & Forecast, By Drug Class (USD Million)
            • Market Size & Forecast, By Formulation (USD Million)
            • Market Size & Forecast, By Therapeutic Area (USD Million)
            • Market Size & Forecast, By End-user (USD Million)
          • Germany
            • Market Size & Forecast, By Molecule (USD Million)
            • Market Size & Forecast, By Drug Class (USD Million)
            • Market Size & Forecast, By Formulation (USD Million)
            • Market Size & Forecast, By Therapeutic Area (USD Million)
            • Market Size & Forecast, By End-user (USD Million)
          • France
            • Market Size & Forecast, By Molecule (USD Million)
            • Market Size & Forecast, By Drug Class (USD Million), & Forecast, By Therapeutic Area (USD Million)
            • Market Size & Forecast, By End-user (USD Million)
          • Italy
            • Market Size & Forecast, By Molecule (USD Million)
            • Market Size & Forecast, By Drug Class (USD Million)
            • Market Size & Forecast, By Formulation (USD Million)
            • Market Size & Forecast, By Therapeutic Area (USD Million)
            • Market Size & Forecast, By End-user (USD Million)
          • Spain
            • Market Size & Forecast, By Molecule (USD Million)
            • Market Size & Forecast, By Drug Class (USD Million)
            • Market Size & Forecast, By Formulation (USD Million)
            • Market Size & Forecast, By Therapeutic Area (USD Million)
            • Market Size & Forecast, By End-user (USD Million)
          • Rest of Europe
            • Market Size & Forecast, By Molecule (USD Million)
            • mp; Forecast, By Formulation (USD Million)
            • Market Size & Forecast, By Therapeutic Area (USD Million)
            • Market Size & Forecast, By End-user (USD Million)
        • Asia Pacific (APAC) Oral Proteins and Peptides Market Size & Forecast (2024-2031), By Country, USD Million
          • China
            • Market Size & Forecast, By Molecule (USD Million)
            • Market Size & Forecast, By Drug Class (USD Million)
            • Market Size & Forecast, By Formulation (USD Million)
            • Market Size & Forecast, By Therapeutic Area (USD Million)
            • Market Size & Forecast, By End-user (USD Million)
          • Japan
            • Market Size & Forecast, By Molecule (USD Million)
            • Market Size & Forecast, By Drug Class (USD Million)
            • Market Size & Forecast, By Formulation (USD Million)
            • Market Size & Forecast, Billion)
          • India
            • Market Size & Forecast, By Molecule (USD Million)
            • Market Size & Forecast, By Drug Class (USD Million)
            • Market Size & Forecast, By Formulation (USD Million)
            • Market Size & Forecast, By Therapeutic Area (USD Million)
            • Market Size & Forecast, By End-user (USD Million)
          • Rest of Asia Pacific
            • Market Size & Forecast, By Molecule (USD Million)
            • Market Size & Forecast, By Drug Class (USD Million)
            • Market Size & Forecast, By Formulation (USD Million)
            • Market Size & Forecast, By Therapeutic Area (USD Million)
            • Market Size & Forecast, By End-user (USD Million)
        • Latin America (LATAM) Oral Proteins and Peptides Market Size & Forecast (2024-2031), USD Million
          • Market Size & Forecast, By Molecule (USD Million) Size & Forecast, By Formulation (USD Million)
          • Market Size & Forecast, By Therapeutic Area (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Middle East & Africa (MEA) Oral Proteins and Peptides Market Size & Forecast (2024-2031), USD Million
          • Market Size & Forecast, By Molecule (USD Million)
          • Market Size & Forecast, By Drug Class (USD Million)
          • Market Size & Forecast, By Formulation (USD Million)
          • Market Size & Forecast, By Therapeutic Area (USD Million)
          • Market Size & Forecast, By End-user (USD Millio"11">
          • Competitive Landscape
            • Key Players and their Competitive Positioning
              • Key Player Comparison
              • Segment-wise Player Mapping
              • Market Share Analysis (2025)
              • Company Categorization Matrix
                • Dominants/Leaders
                • New Entrants
                • Emerging Players
                • Innovative Players
              • Key Strategies Assessment, By Player (2023-2025)
                • New Product Launches
                • Partnerships, Agreements, & Collaborations
                • Mergers & Acquisitions
                • Geographic Expansion
            1. Company Profiles*

            (Business Overview, Financial Performance**, Products Offered, Recent Developments)

            • Novo Nordisk A/S
            • AbbVie Inc.
            • Oramed Pharmaceuticals Inc.
            • Pfizer Inc.
            • Rani Therapeutics Inc.
            • Acadia Pharmaceuticals Inc.
            • Johnson and Johnson
            • AstraZeneca PLC
            • Aurinia Pharmaceuticals Inc.
            • Amgen Inc.
            • Other Prominent Players

            Note: *Indicative list

            **For listed companies

    • Related Reports

    View All Research Reports